DAX24.360 -0,2%Est505.954 -0,5%MSCI World4.343 -0,1%Top 10 Crypto9,7600 +1,1%Nas24.400 ±-0,0%Bitcoin64.670 +0,4%Euro1,1755 -0,3%Öl96,42 +2,8%Gold4.739 -1,7%

Ocular Therapeutix Aktie

Kaufen

Verkaufen

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

7,85 EUR -0,20 EUR -2,48 %

16:47:20

STU

9,20 USD -0,32 USD -3,31 %

17:01:16

BTT

Ocular Therapeutix jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Smartphone

Marktkap.1,82 Mrd. EUR

Div. Rendite0,00%

WKNA1180P

ISINUS67576A1007

SymbolOCUL

Ocular Therapeutix Aktien News

Sortieren:Datum Meistgelesen

18.03.26MotleyFoolWhat to Make of VR Adviser's Big Ocular Therapeutix Sell-Down

23.02.26BenzingaWhat's Driving the Market Sentiment Around Ocular Therapeutix Inc?

18.02.26BenzingaOcular Therapeutix Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

WerbungOcular Therapeutix-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

17.02.26BenzingaOcular Therapeutix Drug Shows Promise In Eye Disorder, But Falls Short of Investor Hopes

05.02.26ZacksOcular Therapeutix (OCUL) Reports Q4 Loss, Misses Revenue Estimates

16.01.26BenzingaPeering Into Ocular Therapeutix Inc's Recent Short Interest

15.01.26BenzingaOcular Therapeutix Shares Surge Following Reports Of Stronger Sanofi Bid

15.01.26ZacksStrength Seen in Ocular Therapeutix (OCUL): Can Its 6.1% Jump Turn into More Strength?

08.12.25BenzingaOcular Therapeutix Stock Skyrockets On Faster FDA Path For Vision Drug

08.12.25BenzingaParamount Skydance, Wave Life Sciences, Ocular Therapeutix, Carvana And Other Big Stocks Moving Higher On Monday

20.11.25ZacksWall Street Analysts Think Ocular Therapeutix (OCUL) Could Surge 82.48%: Read This Before Placing a Bet

04.11.25ZacksOcular Therapeutix (OCUL) Reports Q3 Loss, Tops Revenue Estimates

30.10.25ZacksWall Street Analysts Believe Ocular Therapeutix (OCUL) Could Rally 82.93%: Here's is How to Trade

24.10.25ZacksOcular Therapeutix (OCUL) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

01.10.25BenzingaExpert Outlook: Ocular Therapeutix Through The Eyes Of 4 Analysts

05.08.25ZacksOcular Therapeutix (OCUL) Reports Q2 Loss, Misses Revenue Estimates

25.06.25ZacksOcular Therapeutix (OCUL) Moves 8.6% Higher: Will This Strength Last?

29.05.25BenzingaDemystifying Ocular Therapeutix: Insights From 7 Analyst Reviews

05.05.25BenzingaOcular Therapeutix (OCUL) Stock Drops 13% After Q1 Earnings

05.05.25ZacksOcular Therapeutix (OCUL) Reports Q1 Loss, Misses Revenue Estimates

19.02.24PR NewswireAffaMed Therapeutics Announces New Drug Application Acceptance by Singapore Health Sciences Authority (HSA) for DEXTENZA® for Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery...

19.02.24PR NewswireAffaMed Therapeutics Announces New Drug Application Acceptance by Singapore Health Sciences Authority (HSA) for DEXTENZA® for Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery...

31.10.23PR NewswireAffaMed Therapeutics Announced Positive Top-Line Results from Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA® in Patients after Cataract Surgery

31.10.23PR NewswireAffaMed Therapeutics Announced Positive Top-Line Results from Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA® in Patients after Cataract Surgery

20.09.23PR NewswireAffaMed Therapeutics Announces First Patient Treated in Phase 3 Registrational Clinical Trial in Mainland China for DEXTENZA® for the Treatment of Ocular Inflammation and Pain Following Ophthalmic...

Ocular Therapeutix News

Ocular Therapeutix News: auf dieser Seite finden Sie alle Ocular Therapeutix News und Nachrichten zur Ocular Therapeutix Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Ocular Therapeutix News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Ocular Therapeutix News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.